IPO - Iris Parent Holding Corp.

Form Type: S-1

Filing Date: 2025-06-24

Corporate Action: Ipo

Type: New

Accession Number: 000141057825001432

Filing Summary: On June 24, 2025, Liminatus Pharma, Inc. filed an S-1 registration statement with the SEC indicating its intention to go public. This filing outlines the terms of its upcoming initial public offering (IPO), detailing the number of shares to be offered, the expected price range per share, and the intended use of the proceeds from the offering. The company aims to raise funds to support its research and development efforts, as well as for potential acquisitions and other general corporate purposes. The S-1 document includes financial statements, a description of Liminatus Pharma’s business operations, market analysis, and risk factors associated with the investment, providing potential investors with comprehensive information to evaluate the offering.